회원가입 | 연락처 | 사이트맵 | English

      회사소개 | 리포트 | 커스텀 리서치 | 고객지원


로그인

카테고리

유/무선통신

전기/전자

디지털기기/미디어/방송

Information Technology

에너지

생명공학

화학/신소재

자동차

환경

일반소비재

마케팅/광고

금융

건설

교통/운송

소비자조사

방위/항공/우주

식음료

중공업

교육

기계

무역

스포츠/레저

해운/조선

패션

정부/정책

공예/귀금속

컴퍼니 프로파일

기타산업

 
현재위치 : HOME > 리포트 > 화학/신소재 > 화학
Investigation Report on China Nicergoline Market, 2010-2019
발행사 China Research and Intelligence

발행일 2015-05
분량 30 pages
서비스형태 Report
판매가격

인쇄하기

Description

Nicergoline is a kind of ergot alkaloid, which can dilatate the blood vessel of brain and improve the blood supply of brain. It can block α-receptor and accelerate metabolism as well as reduce the resistance of the blood vessel of brain and increase the blood flow of brain and the usage of glucose to improve mental retardation. Nicergoline can also accelerate the metabolism of dopamine, enhance the nerve conduction, improve the mental and emotional abnormality, accelerate the synthesis of the protein in brain, effectively improve memory, recover the normal function of nerve cells, entirely improve the clinic symptom of chronic brain dysfunction syndrome.

Nicergoline is first researched and produced by Pfizer Co., Ltd., which is widely used for many indications. It spreads to the globe after launching to the market.

Market size of nicergoline and its share in anti-Alzheimer's disease drug market is small as a drug used for 30 years. There are many substitutes and its product lifecycle is in recession. According to CRI's market research, the market size of nicergoline in sample hospitals was about CNY 89 million in 2010 and CNY 76 million in 2014.

In future years, China's nicergoline market will shrank because of the competition of other types of anti-AD drugs like biopharmaceuticals. However, the low-end market demand for nicergoline still exists, the nicergoline drug market won't disappear in a short time.

Through this report, readers can acquire the following information:
-Sales price of nicergoline in hospital market in China
-Market Share of Major Nicergoline Manufacturers in China
-Patent Status of Nicergoline in China
-Market share of Nicergoline by dosage form in hospital market in China
-Prospect of China Nicergoline Market

The Following Enterprises and People Are Recommended to Purchase This Report:
- manufacturers of drug for cardiovascular disease and Alzheimer’s disease
-Investors Focusing on China Drug Market
-CRI also provides other drug market report and custom research.


회사소개 | 개인정보보호정책 | 이용약관 | 배송/결제안내 | 이용안내

서울시 강남구 논현동 210-1 삼원빌딩 | 회사명 : (주)엘앤에치
대표전화 : 02-554-0001 / 팩스 : 02-3444-5501 / 이메일 : sales@landh.co.kr
Copyright ⓒ 2008 LNH, Inc. All rights reserved.